Article
Epitope Engineered Human Haematopoietic Stem Cells are Shielded from CD123-targeted Immunotherapy
2023-07-12
Abstract excerpt
<h4>Summary</h4> Targeted eradication of transformed or otherwise dysregulated cells using monoclonal antibodies (mAb), antibody-drug conjugates (ADC), T cell engagers (TCE) or chimeric antigen receptor (CAR) cells is very effective for haematologic diseases. Unlike the breakthrough progress achieved for B cell malignancies, there is a pressing need to find suitable antigens for immunotherapy of myeloid malignanc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bd7db515-9013-5d34-a1b3-7e75eb9ccdb3
- DOI
- 10.1101/2023.07.11.547391
